BridgeMD
New treatment option for HPV Vaccine
Official title Persistence of Immune Response Six Years After One Dose of 9vHPV Vaccine Among Male and Female Students
ClinicalTrials.gov ID: NCT07156084
What this study is testing
What is HPV nonavalent vaccine (Gardasil-9)?
HPV nonavalent vaccine (Gardasil-9) is an investigational medicine, being studied as a potential treatment for hpv vaccine.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Since the 2019-2020 school year, the province of Quebec (Canada) has been administering one dose of nonavalent (9vHPV) vaccine to students of all genders in Grade 4 of elementary school through the school-based program. Little data on the immunogenicity (antibody production) and long-term efficacy of a single dose of the vaccine are available, particularly in boys.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 15 to 17. Healthy volunteers may be eligible.
You may be able to join if
- Have received a single dose of 9vHPV vaccine at ages 9-11 during the school year 2019-2020;
- Not have received any other HPV vaccine doses;
- Be able to consent to the study.
You likely can't join if
- Immunosuppressed (at recruitment or when immunized).
The study team makes the final eligibility decision.
Where it's taking place
- Québec, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 15 years to 17 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Québec, Quebec, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.